Senate Passes Bill To Expand Cannabis Research

The United States Senate passed a cannabis research expansion bill this week.
Senate Passes Bill To Expand Cannabis Research
Shutterstock

The U.S. Senate approved a bill on Tuesday that would allow for the expansion of scientific research into cannabis and marijuana derivatives including CBD. The bill, known as the Cannabidiol and Marihuana Research Expansion Act (S. 2032), was advanced by unanimous consent and will now head to the House of Representatives for consideration. The House passed a similar measure last week, although provisions in that bill that would allow researchers to use cannabis products from state-licensed dispensaries are not included in the Senate proposal.

The Senate bill’s lead sponsors, Democrats Sen. Dianne Feinstein of California and Sen. Brian Hatch of Hawaii and Iowa Republican Sen. Chuck Grassley, applauded the action in a joint press release on Wednesday. The bill passed on Tuesday combines a bill previously introduced by Senators Feinstein and Grassley (the Cannabidiol Research Expansion Act) with a bill previously introduced by Senator Schatz (the Marijuana Effective Drug Studies Act.)

“Existing regulations make medical marijuana research difficult and have prevented us from understanding exactly how medical marijuana can be used safely and effectively to treat various conditions,” said Feinstein. “Our bill streamlines the research process and paves the way for marijuana-derived medications that are FDA-approved to treat serious medical conditions, like intractable epilepsy, in a way that will keep consumers safe.”

Bill Streamlines Cannabis Research

S. 2032 would expedite the approval process for researchers planning to study cannabis or its derivatives. The measure also includes provisions that would streamline the development of FDA-approved drugs made with marijuana or CBD by allowing accredited medical and osteopathic schools, practitioners, research institutions, and manufacturers with a Schedule I registration to produce marijuana for their research.

“Our bill will remove excessive barriers that make it difficult for researchers to study the effectiveness and safety of marijuana, and hopefully, give patients more treatment options,” said Schatz. “The medical community agrees that we need more research to learn about marijuana’s potential health benefits, but our federal laws today are standing in the way.”

Other provisions of the bill would permit doctors to discuss the potential benefits and risks of marijuana treatments including CBD with their patients and the parents of minors in their care. The measure would also require the Department of Health and Human Services and the National Institutes of Health to submit a report on the potential benefits and harms of marijuana use within one year of the bill’s effective date.

Measure Receives Bipartisan Support

In addition to Feinstein, Grassley, and Schatz, the bill is cosponsored by Senators Dick Durbin (D-Ill.), Amy Klobuchar (D-Minn.), Thom Tillis (R-N.C.), Tim Kaine (D-Va.), Joni Ernst (R-Iowa), Kevin Cramer (R-N.D.), Lamar Alexander (R-Tenn.), Jon Tester (D -Mont.), and Lisa Murkowski (R- Alaska).

“I’ve been a strong supporter and lead Republican of this legislation since it was first introduced in 2016,” said Grassley. “This bipartisan bill is critical to better understanding the marijuana plant and its potential benefits and side effects. It will empower the FDA to analyze CBD and medical marijuana products in a safe and responsible way so that the American public can decide whether to utilize them in the future based on sound scientific data. Researching marijuana is widely supported by my colleagues on both sides of the aisle, and it’s a smart step forward in addressing this current schedule I drug.”

Total
533
Shares
5 comments
  1. One gets threatened to use pot. It’s a hell terror. Just ask users to do a before and after for the way that they feel.

  2. It is the most researched plant on the face of planet earth. What will be the next excuse of the feet and knuckle dragging excuse of these fudderal bozos.

  3. What a great news! Marijuana has already been researched but the thing to be focused on should be deep research. The lawmakers are not aware of the supernatural powers of medical marijuana and the scientists are busy working on almost everything except medical marijuana. People from all over the globe share their success stories. Moreover, marijuana is being used by 65% of the people for certain health issues, out of which anxiety and depression are topping the list. The marijuana industry is progressing day by day and after the elections in 2020 marijuana users excited about the new changes in marijuana legalization bills. There have been many pieces of research that prove the effectiveness of medical marijuana and it has been proven that medical marijuana has no life-threatening side effects and drug overdose death history. https://mdberry.com/medical-marijuana-effectiveness-research/ . These are some latest researches on medical marijuana but would FDA ever pay attention to efforts made by marijuana industry to legalize it complelty??

  4. What about the 50 plus years of research at Ole Miss ? What about Isreal’s research that the US pays for ? Does our govt. refuse to accept it’s own research ? When will it end ?

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article
Arizona to Unveil Licenses and Draft Rules For Legal Cannabis Market

Arizona to Unveil Licenses and Draft Rules For Legal Cannabis Market

Next Article
South Carolina Pre-Files Cannabis Reform Bills

South Carolina Pre-Files Cannabis Reform Bills

Related Posts
Total
533
Share